Overview
Assessing Department-specific Antibiotic Susceptibility to Guide Selection and Improve Outcomes: Management of cUTIs
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
A faculty panel discuss a cases relating to the assessment and treatment of cUTIs. Topics include emerging technologies for diagnosis, common pathogens, and the selection of therapy for resistant gram-negative infections.
This activity is intended for ID specialists, researchers, clinical microbiologists, hospitalists, internists, pharmacists and other healthcare professionals who care for patients at risk of serious infection.
The purpose of this activity is to provide clinicians who care for the patients with serious infections with the latest data on antimicrobial stewardship, available and emerging antibiotics against gram-negative pathogens, and the optimization of therapy to improve outcomes and reduce resistance.
Upon completion of the activity, participants should be able to:
- Discuss the molecular epidemiology of antibiotic resistance in bacterial pathogens
- Compare and contrast antibiotics currently in development for use against gram-negative pathogens
- Describe strategies to optimize antimicrobial therapy to ensure effectiveness of antibiotics and reduce resistance
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Merck & Company
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Patricia (Trish) Simner, PhD, D(ABMM)
Director of Medical Bacteriology and Parasitology Laboratories
Associate Professor of Pathology
Johns Hopkins School of Medicine
Baltimore, MD
Jason M. Pogue, PharmD, BCPS, BCIDP
Clinical Assistant Professor of Medicine
Wayne State University School of Medicine
Detroit, MI
Pranita D. Tamma, MD, MHS
Director, Pediatric Antimicrobial Stewardship Program
Associate Professor of Pediatrics
Johns Hopkins University School of Medicine
Baltimore, MD
Featuring New Indication Video From
James Lewis, II, PharmD, FIDSA
Infectious Disease Clinical Pharmacy Supervisor
Co-Director of Antibiotic Stewardship
Oregon Health & Science University
Director of Medical Bacteriology and Parasitology Laboratories
Associate Professor of Pathology
Johns Hopkins School of Medicine
Baltimore, MD
Jason M. Pogue, PharmD, BCPS, BCIDP
Clinical Assistant Professor of Medicine
Wayne State University School of Medicine
Detroit, MI
Pranita D. Tamma, MD, MHS
Director, Pediatric Antimicrobial Stewardship Program
Associate Professor of Pediatrics
Johns Hopkins University School of Medicine
Baltimore, MD
Featuring New Indication Video From
James Lewis, II, PharmD, FIDSA
Infectious Disease Clinical Pharmacy Supervisor
Co-Director of Antibiotic Stewardship
Oregon Health & Science University
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
The following financial relationships have been provided:
Jason Pogue, PharmD
Consultant: Melinta, Merck, Nabriva, Shionogi, and Tetraphase
Speakers Bureau: Melinta and MerckGrant Support: Merck
Patricia J. Simner, MSc, PhD:
Consultant: Accelerate Diagnostics, CosmosID, OpGen Inc., and Roche Diagnostics
Research Grants: Accelerate Diagnostics, Affinity Biosensors, Check-Points BV, Hardy Diagnostics, and OpGen Inc.
Pranita D. Tamma, MD, MHS
Research Grants: Merck
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Novel antibiotics and available antibiotics under investigation for use in different types of serious infections.
The following financial relationships have been provided:
Jason Pogue, PharmD
Consultant: Melinta, Merck, Nabriva, Shionogi, and Tetraphase
Speakers Bureau: Melinta and MerckGrant Support: Merck
Patricia J. Simner, MSc, PhD:
Consultant: Accelerate Diagnostics, CosmosID, OpGen Inc., and Roche Diagnostics
Research Grants: Accelerate Diagnostics, Affinity Biosensors, Check-Points BV, Hardy Diagnostics, and OpGen Inc.
Pranita D. Tamma, MD, MHS
Research Grants: Merck
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Novel antibiotics and available antibiotics under investigation for use in different types of serious infections.
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 30 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.